优化苯妥英治疗:食物与草药相互作用的系统综述
结果显示部分成分可增强吸收或疗效,部分可降低疗效;与叶酸同服可能预防缺乏而不影响血药浓度,与胡椒碱同用需监测,应避免与诺丽同用。
要点
- 苯妥英与叶酸同服可能预防缺乏且不影响血药浓度或疗效。
- 苯妥英与胡椒碱同用需监测吸收和血浆浓度变化。
- 应避免苯妥英与诺丽同用,可能使浓度降至亚治疗水平。
核心结论
- 苯妥英与食物、草药存在临床显著相互作用,可增强或降低吸收与疗效,需个体化监测。
主要发现
- 3篇报告无相互作用,5篇报告药物吸收增强,1篇报告药物有效性改善。
- 3篇报告因特定食物或草药相互作用导致疗效降低。
关键数值与推荐
- 与叶酸同服可能预防缺乏而不影响血浆浓度或药物疗效。
- 与胡椒碱同用需监测潜在吸收增加和血浆水平升高。
- 建议避免诺丽与苯妥英同用,可能使苯妥英浓度降至亚治疗水平。
临床怎么用
- 处方苯妥英时应询问食物与草药使用情况,对胡椒碱和诺丽等相互作用风险进行监测或避免。
- 对叶酸缺乏风险患者可考虑同服叶酸,但需基于中等质量证据个体化决策。
局限性
- 纳入研究证据质量多为中等,需进一步对照临床试验优化药理学建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Phenytoin, a widely prescribed anticonvulsant, presents clinical challenges due to its narrow therapeutic index and potential interactions with various foods, herbs, and medications. These interactions can lead to adverse effects or subtherapeutic responses, necessitating a thorough understanding by healthcare professionals to optimize patient care. METHODS: This systematic review investigates clinically significant interactions between phenytoin and dietary components. A comprehensive search across PubMed, Scopus, and the Health Virtual Library identified relevant studies published from January 1960 to December 2024. Data extraction utilized standardized forms, and evidence certainty was evaluated using the GRADE criteria. RESULTS: Twelve of the 826 initially identified articles met the inclusion criteria. Findings revealed diverse interactions: three articles reported no interaction, five indicated enhanced drug absorption, and one noted improved drug effectiveness. Conversely, three studies documented reduced efficacy due to interactions with specific foods or herbs. DISCUSSION: The review suggests that co-administration of phenytoin with folic acid may prevent deficiency without affecting plasma concentrations or drug efficacy. Concurrent use of phenytoin and piperine should be monitored due to potential absorption and increases in plasma levels. Additionally, it is suggested that the combination of noni and phenytoin be avoided, as it may reduce phenytoin concentrations to subtherapeutic levels. While these findings are based on studies of moderate evidence quality, further controlled clinical trials are necessary to refine pharmacological recommendations. SYSTEMATIC REVIEW REGISTRATION: CRD42018117308.
引用
- Orellana-Paucar AM, Mosquera-Lopez ET, Bustamante-Alvarez NM, et al. Optimizing phenytoin therapy: a systematic review of clinically relevant food and herb interactions. Front Pharmacol. 2026. PMID: 41560756. doi:10.3389/fphar.2025.1676685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。